Sérgio Valente - Concepedia

Author

Sérgio Valente

Also Known As

Chereau, Christiane, Florent Dingli, Lindeboom, R.G.H., Rossella Fioravanti, S Valente, S. Valente, S.F. Valente, SERGIO VALENTE, Sergio Valente, Sergio Valente Flores Miranda

243

Publications

8.2K

Citations

H-Index

128

Concepts

All Affiliations

Sapienza University of Rome Istituto Pasteur University of Naples Federico II Istituti di Ricovero e Cura a Carattere Scientifico University of Campania "Luigi Vanvitelli"

About

Sérgio Valente is an author at Sapienza University of Rome specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	58	3.3K
2	Natural Sciences	23	28	1.5K
3	Health Sciences	4	4	462
4	Engineering	3	3	169
5	Public Health	1	1	39

Sérgio Valente

116

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration Daniela Palacios, Chiara Mozzetta, Silvia Consalvi, Cell stem cell InflammationCytokineSignal TransductionSignaling PathwayImmune Cell Development	2010	379
Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2 Claudia Binda, Sérgio Valente, Mauro Romanenghi, Journal of the American Chemical Society Drug TargetChromatin StateLsd2 Histone DemethylasesChemical BiologyPharmaceutical Chemistry	2010	283
Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue Andrea Galmozzi, Nico Mitro, Alessandra Ferrari, Diabetes Metabolic RemodelingRedox BiologyInsulin SignalingChromatin ModificationsOxidative Stress	2012	231
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors Jay H. Kalin, Muzhou Wu, Andrea V. Gómez, Nature Communications	2018	228
Study of 1,4-Dihydropyridine Structural Scaffold: Discovery of Novel Sirtuin Activators and Inhibitors Antonello Mai, Sérgio Valente, Sarah Meade, Journal of Medicinal Chemistry	2009	159
Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors Antonello Mai, Donghang Cheng, Mark T. Bedford, Journal of Medicinal Chemistry	2008	132
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC–MEF2 complexes Angela Nebbioso, Fabio Manzo, Marco Miceli, EMBO Reports	2009	131
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells Sérgio Valente, Daniela Trisciuoglio, Teresa De Luca, Journal of Medicinal Chemistry Hematological MalignancyMedicinal ChemistryChemoprevention StrategyMedicineMixed-phenotype Acute Leukemia	2014	131
Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells Sérgio Valente, Yiwei Liu, Michaël Schnekenburger, Journal of Medicinal Chemistry Epigenetic ChangeDna MethylationCancer BiologyEpigeneticsSelective Non-nucleoside Inhibitors	2014	129
GreenMedChem: the challenge in the next decade toward eco-friendly compounds and processes in drug design Carola Castiello, Pierre Junghanns, Annika M. Mergel, Green Chemistry EngineeringGreen ChemistryGreenness AssessmentGreen InnovationOrganic Chemistry	2023	127

Page 1